Evidence map›Paper›PMID 34815785›Full record

ArticleTheranostics2021

Identification of three tumor antigens and immune subtypes for mRNA vaccine development in diffuse glioma.

Quanwei Zhou, Xuejun Yan, Hecheng Zhu, Zhaoqi Xin, Jin Zhao, Wenyue Shen, Wen Yin, Youwei Guo, Hongjuan Xu, Ming Zhao and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Theranostics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
8.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Gene Expression Patterns Associated with Survival in Glioblastoma.International journal of molecular sciences · 2024
    Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. RNA modification in mRNA cancer vaccines.Clinical and experimental medicine · 2023
    Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Quanwei ZhouDepartment of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan Province, 410008, China.
Xuejun YanCancer Research Institute, School of Basic Medical Science, Central South University, Changsha, China.
Hecheng ZhuChangsha Kexin Cancer Hospital, Changsha, Hunan 410205, China.
Zhaoqi XinDepartment of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan Province, 410008, China.
Jin ZhaoCancer Research Institute, School of Basic Medical Science, Central South University, Changsha, China.
Wenyue ShenDepartment of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan Province, 410008, China.
Wen YinDepartment of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan Province, 410008, China.
Youwei GuoDepartment of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan Province, 410008, China.
Hongjuan XuCancer Research Institute, School of Basic Medical Science, Central South University, Changsha, China.
Ming ZhaoChangsha Kexin Cancer Hospital, Changsha, Hunan 410205, China.
Weidong LiuCancer Research Institute, School of Basic Medical Science, Central South University, Changsha, China.
Xingjun JiangDepartment of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan Province, 410008, China.
Caiping RenDepartment of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan Province, 410008, China.
Central South University · CNXiangya Hospital Central South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antigens, NeoplasmBiomarkers, TumorBrain NeoplasmsCancer VaccinesChinaCollagen Type IDatabases, GeneticGene ExpressionGene Expression ProfilingGene Expression Regulation, NeoplasticGliomaHumansImmunotherapyIntracellular Signaling Peptides and ProteinsmRNA VaccinesPrognosisAntigens, NeoplasmBiomarkers, TumorCancer VaccinesCOL1A2 protein, humanCollagen Type IIntracellular Signaling Peptides and ProteinsKDR protein, humanmRNA VaccinesRNA, MessengerSAMD9 protein, humanVascular Endothelial Growth Factor Receptor-2diffuse gliomaimmune subtypesmRNA vaccinetumor antigentumor immune infiltration

Identifiers

PMID34815785
PMCPMC8581422
OpenAlexW3209991562

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.